Ross Cummings

UK Biotech patent application searches: cheap as DNA chips!

Biotech patent applicants filing their priority applications at the UK Intellectual Property Office (UKIPO) could now benefit from significant savings in search fees. This is another great reason to file your first applications in the UK. The UKIPO has today officially announced that they will be working with the European...

Read more

FierceBiotech Executive Summit

On Tuesday 30 October, Ross Cummings will be attending the FierceBiotech Executive Summit at the Royal Society of Medicine. The half-day summit will gather industry experts to discuss the infrastructures of biomedical sciences across the UK and the challenges and opportunities to the life sciences sector amid a time of...

Read more

UK Bioscience Forum

On Thursday 18 October, Ross Cummings will be attending the UK Bioscience Forum at the Queen Elizabeth II Conference Centre in Westminster. The forum, hosted by the BIA, will be a day filled with presentations and panel discussions which will focus on the practical and key issues for the bioscience...

Read more

In a new age of personalised cancer therapy, is patent law in Europe still fit for purpose?

In the last week it has been announced that the NHS has struck a deal with Novartis to offer their ground-breaking new CAR-T therapy, Kymriah®, to paediatric patients with B cell acute lymphoblastic leukaemia. This is a significant development and means that some patients will now have access to this...

Read more

Pilots4U Workshop

Ross Cummings will be speaking at the Pilots4U Workshop ‘Scale me up, Scotty’ on 18 April in Brussels. The workshop will present and discuss different open access cooperation models and highlight common agreements regarding Intellectual property rights. The workshop intends to inform (and discuss with) pilot infrastructure owners and users...

Read more